These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16918129)

  • 1. Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
    Fuggetta MP; Lanzilli G; Tricarico M; Cottarelli A; Falchetti R; Ravagnan G; Bonmassar E
    J Exp Clin Cancer Res; 2006 Jun; 25(2):189-93. PubMed ID: 16918129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
    Lanzilli G; Fuggetta MP; Tricarico M; Cottarelli A; Serafino A; Falchetti R; Ravagnan G; Turriziani M; Adamo R; Franzese O; Bonmassar E
    Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
    Bishayee A; Dhir N
    Chem Biol Interact; 2009 May; 179(2-3):131-44. PubMed ID: 19073162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells.
    Li Y; Bäckesjö CM; Haldosén LA; Lindgren U
    Eur J Pharmacol; 2009 May; 609(1-3):13-8. PubMed ID: 19285066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation.
    Alkhalaf M
    Eur J Cancer Prev; 2007 Aug; 16(4):334-41. PubMed ID: 17554206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimyeloma effects of resveratrol through inhibition of angiogenesis.
    Hu Y; Sun CY; Huang J; Hong L; Zhang L; Chu ZB
    Chin Med J (Engl); 2007 Oct; 120(19):1672-7. PubMed ID: 17935668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibits cell cycle progression in U937 cells.
    Castello L; Tessitore L
    Oncol Rep; 2005 Jan; 13(1):133-7. PubMed ID: 15583814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.
    Ménoret A; Drew DA; Miyamoto S; Nakanishi M; Vella AT; Rosenberg DW
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E11-22. PubMed ID: 23255428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells.
    Marel AK; Lizard G; Izard JC; Latruffe N; Delmas D
    Mol Nutr Food Res; 2008 May; 52(5):538-48. PubMed ID: 18384089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells.
    Mgbonyebi OP; Russo J; Russo IH
    Int J Oncol; 1998 Apr; 12(4):865-9. PubMed ID: 9499448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
    Hsieh TC
    Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells.
    Juan ME; Wenzel U; Daniel H; Planas JM
    J Agric Food Chem; 2008 Jun; 56(12):4813-8. PubMed ID: 18522405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.
    Aires V; Limagne E; Cotte AK; Latruffe N; Ghiringhelli F; Delmas D
    Mol Nutr Food Res; 2013 Jul; 57(7):1170-81. PubMed ID: 23495229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules.
    Li H; Wu WK; Zheng Z; Che CT; Yu L; Li ZJ; Wu YC; Cheng KW; Yu J; Cho CH; Wang M
    Biochem Pharmacol; 2009 Nov; 78(9):1224-32. PubMed ID: 19591809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Australian fruit Illawarra plum (Podocarpus elatus Endl., Podocarpaceae) inhibits telomerase, increases histone deacetylase activity and decreases proliferation of colon cancer cells.
    Symonds EL; Konczak I; Fenech M
    Br J Nutr; 2013 Jun; 109(12):2117-25. PubMed ID: 23069328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
    Joe AK; Liu H; Suzui M; Vural ME; Xiao D; Weinstein IB
    Clin Cancer Res; 2002 Mar; 8(3):893-903. PubMed ID: 11895924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma.
    Cosan DT; Bayram B; Soyocak A; Basaran A; Gunes HV; Degirmenci I; Musmul A
    Cancer Biother Radiopharm; 2010 Oct; 25(5):577-80. PubMed ID: 20874429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
    Parekh P; Motiwale L; Naik N; Rao KV
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):167-73. PubMed ID: 20133117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
    Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
    Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.